By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.
Scott Gottlieb and Luciana Borio, a former director for medical and biodefense preparedness policy at the National Security ...
Priority review granted for CUTX-101 with PDUFA target action date set for June 30, 2025Cyprium is eligible to receive royalties and up to $129 ...
Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...
Produce supplier Braga Fresh has issued a ‘precautionary advisory’ about the product, which is no longer in stores but might ...
Trump's staff is laying the groundwork to prepare for a new FDA commissioner and make their mark at the agency.
Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...
A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...
The Food and Drug Administration (FDA) will begin collecting samples of raw cow’s milk cheese from across the U.S. to test ...